0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Nasal Spray Live Attenuated Vaccine Market Research Report 2026
Published Date: 2026-04-08
|
Report Code: QYRE-Auto-22F16944
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Nasal Spray Live Attenuated Vaccine Market Research Report 2024
BUY CHAPTERS

Global Nasal Spray Live Attenuated Vaccine Market Research Report 2026

Code: QYRE-Auto-22F16944
Report
2026-04-08
Pages:112
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Nasal Spray Live Attenuated Vaccine Market

The global Nasal Spray Live Attenuated Vaccine market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Nasal Spray Live Attenuated Vaccine competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Nasal spray live attenuated vaccine is a live attenuated viral vaccine administered by nasal spray for the prevention of infection against specific diseases. This vaccine injects a weakened live virus into the body through the nasal mucosal route, which activates the immune system to produce a protective immune response against the disease.
The North American market for Nasal Spray Live Attenuated Vaccine is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Nasal Spray Live Attenuated Vaccine is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Nasal Spray Live Attenuated Vaccine include AstraZeneca, Sanofi, CSL, BioDiem, SEQIRUS, INC., Changchun BCHT Biotechnology Co., Serum Institute, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Nasal Spray Live Attenuated Vaccine market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Nasal Spray Live Attenuated Vaccine. The Nasal Spray Live Attenuated Vaccine market size, estimates, and forecasts are provided in terms of sales volume (K Dose) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Nasal Spray Live Attenuated Vaccine market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Nasal Spray Live Attenuated Vaccine manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Nasal Spray Live Attenuated Vaccine Market Report

Report Metric Details
Report Name Nasal Spray Live Attenuated Vaccine Market
Segment by Type
  • Trivalent Nasal Spray Live Attenuated Vaccine
  • Quadrivalent Nasal Spray Live Attenuated Vaccine
by Application
  • Hospitals & Clinics
  • Public Health Organizations
  • Research Organizations
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company AstraZeneca, Sanofi, CSL, BioDiem, SEQIRUS, INC., Changchun BCHT Biotechnology Co., Serum Institute
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Nasal Spray Live Attenuated Vaccine manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Nasal Spray Live Attenuated Vaccine sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Nasal Spray Live Attenuated Vaccine Market report?

Ans: The main players in the Nasal Spray Live Attenuated Vaccine Market are AstraZeneca, Sanofi, CSL, BioDiem, SEQIRUS, INC., Changchun BCHT Biotechnology Co., Serum Institute

What are the Application segmentation covered in the Nasal Spray Live Attenuated Vaccine Market report?

Ans: The Applications covered in the Nasal Spray Live Attenuated Vaccine Market report are Hospitals & Clinics, Public Health Organizations, Research Organizations, Others

What are the Type segmentation covered in the Nasal Spray Live Attenuated Vaccine Market report?

Ans: The Types covered in the Nasal Spray Live Attenuated Vaccine Market report are Trivalent Nasal Spray Live Attenuated Vaccine, Quadrivalent Nasal Spray Live Attenuated Vaccine

1 Nasal Spray Live Attenuated Vaccine Market Overview
1.1 Product Definition
1.2 Nasal Spray Live Attenuated Vaccine by Type
1.2.1 Global Nasal Spray Live Attenuated Vaccine Market Value by Type: 2025 vs 2032
1.2.2 Trivalent Nasal Spray Live Attenuated Vaccine
1.2.3 Quadrivalent Nasal Spray Live Attenuated Vaccine
1.3 Nasal Spray Live Attenuated Vaccine by Application
1.3.1 Global Nasal Spray Live Attenuated Vaccine Market Value by Application: 2025 vs 2032
1.3.2 Hospitals & Clinics
1.3.3 Public Health Organizations
1.3.4 Research Organizations
1.3.5 Others
1.4 Global Nasal Spray Live Attenuated Vaccine Market Size Estimates and Forecasts
1.4.1 Global Nasal Spray Live Attenuated Vaccine Revenue 2021–2032
1.4.2 Global Nasal Spray Live Attenuated Vaccine Sales 2021–2032
1.4.3 Global Nasal Spray Live Attenuated Vaccine Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Nasal Spray Live Attenuated Vaccine Market Competition by Manufacturers
2.1 Global Nasal Spray Live Attenuated Vaccine Sales Market Share by Manufacturers (2021–2026)
2.2 Global Nasal Spray Live Attenuated Vaccine Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Nasal Spray Live Attenuated Vaccine Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Nasal Spray Live Attenuated Vaccine, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Nasal Spray Live Attenuated Vaccine, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Nasal Spray Live Attenuated Vaccine, Product Types and Applications
2.7 Global Key Manufacturers of Nasal Spray Live Attenuated Vaccine, Date of Entry into the Industry
2.8 Global Nasal Spray Live Attenuated Vaccine Market Competitive Situation and Trends
2.8.1 Global Nasal Spray Live Attenuated Vaccine Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Nasal Spray Live Attenuated Vaccine Players Market Share by Revenue
2.8.3 Global Nasal Spray Live Attenuated Vaccine Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Nasal Spray Live Attenuated Vaccine Market Scenario by Region
3.1 Global Nasal Spray Live Attenuated Vaccine Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Nasal Spray Live Attenuated Vaccine Sales by Region: 2021–2032
3.2.1 Global Nasal Spray Live Attenuated Vaccine Sales by Region: 2021–2026
3.2.2 Global Nasal Spray Live Attenuated Vaccine Sales by Region: 2027–2032
3.3 Global Nasal Spray Live Attenuated Vaccine Revenue by Region: 2021–2032
3.3.1 Global Nasal Spray Live Attenuated Vaccine Revenue by Region: 2021–2026
3.3.2 Global Nasal Spray Live Attenuated Vaccine Revenue by Region: 2027–2032
3.4 North America Nasal Spray Live Attenuated Vaccine Market Facts & Figures by Country
3.4.1 North America Nasal Spray Live Attenuated Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Nasal Spray Live Attenuated Vaccine Sales by Country (2021–2032)
3.4.3 North America Nasal Spray Live Attenuated Vaccine Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Nasal Spray Live Attenuated Vaccine Market Facts & Figures by Country
3.5.1 Europe Nasal Spray Live Attenuated Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Nasal Spray Live Attenuated Vaccine Sales by Country (2021–2032)
3.5.3 Europe Nasal Spray Live Attenuated Vaccine Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Nasal Spray Live Attenuated Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Nasal Spray Live Attenuated Vaccine Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Nasal Spray Live Attenuated Vaccine Sales by Region (2021–2032)
3.6.3 Asia Pacific Nasal Spray Live Attenuated Vaccine Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Nasal Spray Live Attenuated Vaccine Market Facts & Figures by Country
3.7.1 Latin America Nasal Spray Live Attenuated Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Nasal Spray Live Attenuated Vaccine Sales by Country (2021–2032)
3.7.3 Latin America Nasal Spray Live Attenuated Vaccine Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Nasal Spray Live Attenuated Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Nasal Spray Live Attenuated Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Nasal Spray Live Attenuated Vaccine Sales by Country (2021–2032)
3.8.3 Middle East and Africa Nasal Spray Live Attenuated Vaccine Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Nasal Spray Live Attenuated Vaccine Sales by Type (2021–2032)
4.1.1 Global Nasal Spray Live Attenuated Vaccine Sales by Type (2021–2026)
4.1.2 Global Nasal Spray Live Attenuated Vaccine Sales by Type (2027–2032)
4.1.3 Global Nasal Spray Live Attenuated Vaccine Sales Market Share by Type (2021–2032)
4.2 Global Nasal Spray Live Attenuated Vaccine Revenue by Type (2021–2032)
4.2.1 Global Nasal Spray Live Attenuated Vaccine Revenue by Type (2021–2026)
4.2.2 Global Nasal Spray Live Attenuated Vaccine Revenue by Type (2027–2032)
4.2.3 Global Nasal Spray Live Attenuated Vaccine Revenue Market Share by Type (2021–2032)
4.3 Global Nasal Spray Live Attenuated Vaccine Price by Type (2021–2032)
5 Segment by Application
5.1 Global Nasal Spray Live Attenuated Vaccine Sales by Application (2021–2032)
5.1.1 Global Nasal Spray Live Attenuated Vaccine Sales by Application (2021–2026)
5.1.2 Global Nasal Spray Live Attenuated Vaccine Sales by Application (2027–2032)
5.1.3 Global Nasal Spray Live Attenuated Vaccine Sales Market Share by Application (2021–2032)
5.2 Global Nasal Spray Live Attenuated Vaccine Revenue by Application (2021–2032)
5.2.1 Global Nasal Spray Live Attenuated Vaccine Revenue by Application (2021–2026)
5.2.2 Global Nasal Spray Live Attenuated Vaccine Revenue by Application (2027–2032)
5.2.3 Global Nasal Spray Live Attenuated Vaccine Revenue Market Share by Application (2021–2032)
5.3 Global Nasal Spray Live Attenuated Vaccine Price by Application (2021–2032)
6 Key Companies Profiled
6.1 AstraZeneca
6.1.1 AstraZeneca Company Information
6.1.2 AstraZeneca Description and Business Overview
6.1.3 AstraZeneca Nasal Spray Live Attenuated Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 AstraZeneca Nasal Spray Live Attenuated Vaccine Product Portfolio
6.1.5 AstraZeneca Recent Developments/Updates
6.2 Sanofi
6.2.1 Sanofi Company Information
6.2.2 Sanofi Description and Business Overview
6.2.3 Sanofi Nasal Spray Live Attenuated Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Sanofi Nasal Spray Live Attenuated Vaccine Product Portfolio
6.2.5 Sanofi Recent Developments/Updates
6.3 CSL
6.3.1 CSL Company Information
6.3.2 CSL Description and Business Overview
6.3.3 CSL Nasal Spray Live Attenuated Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 CSL Nasal Spray Live Attenuated Vaccine Product Portfolio
6.3.5 CSL Recent Developments/Updates
6.4 BioDiem
6.4.1 BioDiem Company Information
6.4.2 BioDiem Description and Business Overview
6.4.3 BioDiem Nasal Spray Live Attenuated Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 BioDiem Nasal Spray Live Attenuated Vaccine Product Portfolio
6.4.5 BioDiem Recent Developments/Updates
6.5 SEQIRUS, INC.
6.5.1 SEQIRUS, INC. Company Information
6.5.2 SEQIRUS, INC. Description and Business Overview
6.5.3 SEQIRUS, INC. Nasal Spray Live Attenuated Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 SEQIRUS, INC. Nasal Spray Live Attenuated Vaccine Product Portfolio
6.5.5 SEQIRUS, INC. Recent Developments/Updates
6.6 Changchun BCHT Biotechnology Co.
6.6.1 Changchun BCHT Biotechnology Co. Company Information
6.6.2 Changchun BCHT Biotechnology Co. Description and Business Overview
6.6.3 Changchun BCHT Biotechnology Co. Nasal Spray Live Attenuated Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Changchun BCHT Biotechnology Co. Nasal Spray Live Attenuated Vaccine Product Portfolio
6.6.5 Changchun BCHT Biotechnology Co. Recent Developments/Updates
6.7 Serum Institute
6.7.1 Serum Institute Company Information
6.7.2 Serum Institute Description and Business Overview
6.7.3 Serum Institute Nasal Spray Live Attenuated Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Serum Institute Nasal Spray Live Attenuated Vaccine Product Portfolio
6.7.5 Serum Institute Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Nasal Spray Live Attenuated Vaccine Industry Chain Analysis
7.2 Nasal Spray Live Attenuated Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Nasal Spray Live Attenuated Vaccine Production Mode & Process Analysis
7.4 Nasal Spray Live Attenuated Vaccine Sales and Marketing
7.4.1 Nasal Spray Live Attenuated Vaccine Sales Channels
7.4.2 Nasal Spray Live Attenuated Vaccine Distributors
7.5 Nasal Spray Live Attenuated Vaccine Customer Analysis
8 Nasal Spray Live Attenuated Vaccine Market Dynamics
8.1 Nasal Spray Live Attenuated Vaccine Industry Trends
8.2 Nasal Spray Live Attenuated Vaccine Market Drivers
8.3 Nasal Spray Live Attenuated Vaccine Market Challenges
8.4 Nasal Spray Live Attenuated Vaccine Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Nasal Spray Live Attenuated Vaccine Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Nasal Spray Live Attenuated Vaccine Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Nasal Spray Live Attenuated Vaccine Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Nasal Spray Live Attenuated Vaccine Sales (K Dose) of Key Manufacturers (2021–2026)
 Table 5. Global Nasal Spray Live Attenuated Vaccine Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Nasal Spray Live Attenuated Vaccine Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Nasal Spray Live Attenuated Vaccine Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Nasal Spray Live Attenuated Vaccine Average Price (US$/Dose) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Nasal Spray Live Attenuated Vaccine, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Nasal Spray Live Attenuated Vaccine, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Nasal Spray Live Attenuated Vaccine, Product Types and Applications
 Table 12. Global Key Manufacturers of Nasal Spray Live Attenuated Vaccine, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Nasal Spray Live Attenuated Vaccine Companies by Tier (Tier 1, Tier 2, Tier 3), based on Nasal Spray Live Attenuated Vaccine Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Nasal Spray Live Attenuated Vaccine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Nasal Spray Live Attenuated Vaccine Sales by Region (K Dose), 2021–2026
 Table 18. Global Nasal Spray Live Attenuated Vaccine Sales Market Share by Region (2021–2026)
 Table 19. Global Nasal Spray Live Attenuated Vaccine Sales by Region (K Dose), 2027–2032
 Table 20. Global Nasal Spray Live Attenuated Vaccine Sales Market Share by Region (2027–2032)
 Table 21. Global Nasal Spray Live Attenuated Vaccine Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Nasal Spray Live Attenuated Vaccine Revenue Market Share by Region (2021–2026)
 Table 23. Global Nasal Spray Live Attenuated Vaccine Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Nasal Spray Live Attenuated Vaccine Revenue Market Share by Region (2027–2032)
 Table 25. North America Nasal Spray Live Attenuated Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Nasal Spray Live Attenuated Vaccine Sales by Country (K Dose), 2021–2026
 Table 27. North America Nasal Spray Live Attenuated Vaccine Sales by Country (K Dose), 2027–2032
 Table 28. North America Nasal Spray Live Attenuated Vaccine Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Nasal Spray Live Attenuated Vaccine Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Nasal Spray Live Attenuated Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Nasal Spray Live Attenuated Vaccine Sales by Country (K Dose), 2021–2026
 Table 32. Europe Nasal Spray Live Attenuated Vaccine Sales by Country (K Dose), 2027–2032
 Table 33. Europe Nasal Spray Live Attenuated Vaccine Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Nasal Spray Live Attenuated Vaccine Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Nasal Spray Live Attenuated Vaccine Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Nasal Spray Live Attenuated Vaccine Sales by Region (K Dose), 2021–2026
 Table 37. Asia Pacific Nasal Spray Live Attenuated Vaccine Sales by Region (K Dose), 2027–2032
 Table 38. Asia Pacific Nasal Spray Live Attenuated Vaccine Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Nasal Spray Live Attenuated Vaccine Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Nasal Spray Live Attenuated Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Nasal Spray Live Attenuated Vaccine Sales by Country (K Dose), 2021–2026
 Table 42. Latin America Nasal Spray Live Attenuated Vaccine Sales by Country (K Dose), 2027–2032
 Table 43. Latin America Nasal Spray Live Attenuated Vaccine Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Nasal Spray Live Attenuated Vaccine Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Nasal Spray Live Attenuated Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Nasal Spray Live Attenuated Vaccine Sales by Country (K Dose), 2021–2026
 Table 47. Middle East and Africa Nasal Spray Live Attenuated Vaccine Sales by Country (K Dose), 2027–2032
 Table 48. Middle East and Africa Nasal Spray Live Attenuated Vaccine Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Nasal Spray Live Attenuated Vaccine Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Nasal Spray Live Attenuated Vaccine Sales (K Dose) by Type (2021–2026)
 Table 51. Global Nasal Spray Live Attenuated Vaccine Sales (K Dose) by Type (2027–2032)
 Table 52. Global Nasal Spray Live Attenuated Vaccine Sales Market Share by Type (2021–2026)
 Table 53. Global Nasal Spray Live Attenuated Vaccine Sales Market Share by Type (2027–2032)
 Table 54. Global Nasal Spray Live Attenuated Vaccine Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Nasal Spray Live Attenuated Vaccine Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Nasal Spray Live Attenuated Vaccine Revenue Market Share by Type (2021–2026)
 Table 57. Global Nasal Spray Live Attenuated Vaccine Revenue Market Share by Type (2027–2032)
 Table 58. Global Nasal Spray Live Attenuated Vaccine Price (US$/Dose) by Type (2021–2026)
 Table 59. Global Nasal Spray Live Attenuated Vaccine Price (US$/Dose) by Type (2027–2032)
 Table 60. Global Nasal Spray Live Attenuated Vaccine Sales (K Dose) by Application (2021–2026)
 Table 61. Global Nasal Spray Live Attenuated Vaccine Sales (K Dose) by Application (2027–2032)
 Table 62. Global Nasal Spray Live Attenuated Vaccine Sales Market Share by Application (2021–2026)
 Table 63. Global Nasal Spray Live Attenuated Vaccine Sales Market Share by Application (2027–2032)
 Table 64. Global Nasal Spray Live Attenuated Vaccine Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Nasal Spray Live Attenuated Vaccine Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Nasal Spray Live Attenuated Vaccine Revenue Market Share by Application (2021–2026)
 Table 67. Global Nasal Spray Live Attenuated Vaccine Revenue Market Share by Application (2027–2032)
 Table 68. Global Nasal Spray Live Attenuated Vaccine Price (US$/Dose) by Application (2021–2026)
 Table 69. Global Nasal Spray Live Attenuated Vaccine Price (US$/Dose) by Application (2027–2032)
 Table 70. AstraZeneca Company Information
 Table 71. AstraZeneca Description and Business Overview
 Table 72. AstraZeneca Nasal Spray Live Attenuated Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 73. AstraZeneca Nasal Spray Live Attenuated Vaccine Product
 Table 74. AstraZeneca Recent Developments/Updates
 Table 75. Sanofi Company Information
 Table 76. Sanofi Description and Business Overview
 Table 77. Sanofi Nasal Spray Live Attenuated Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 78. Sanofi Nasal Spray Live Attenuated Vaccine Product
 Table 79. Sanofi Recent Developments/Updates
 Table 80. CSL Company Information
 Table 81. CSL Description and Business Overview
 Table 82. CSL Nasal Spray Live Attenuated Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 83. CSL Nasal Spray Live Attenuated Vaccine Product
 Table 84. CSL Recent Developments/Updates
 Table 85. BioDiem Company Information
 Table 86. BioDiem Description and Business Overview
 Table 87. BioDiem Nasal Spray Live Attenuated Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 88. BioDiem Nasal Spray Live Attenuated Vaccine Product
 Table 89. BioDiem Recent Developments/Updates
 Table 90. SEQIRUS, INC. Company Information
 Table 91. SEQIRUS, INC. Description and Business Overview
 Table 92. SEQIRUS, INC. Nasal Spray Live Attenuated Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 93. SEQIRUS, INC. Nasal Spray Live Attenuated Vaccine Product
 Table 94. SEQIRUS, INC. Recent Developments/Updates
 Table 95. Changchun BCHT Biotechnology Co. Company Information
 Table 96. Changchun BCHT Biotechnology Co. Description and Business Overview
 Table 97. Changchun BCHT Biotechnology Co. Nasal Spray Live Attenuated Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 98. Changchun BCHT Biotechnology Co. Nasal Spray Live Attenuated Vaccine Product
 Table 99. Changchun BCHT Biotechnology Co. Recent Developments/Updates
 Table 100. Serum Institute Company Information
 Table 101. Serum Institute Description and Business Overview
 Table 102. Serum Institute Nasal Spray Live Attenuated Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 103. Serum Institute Nasal Spray Live Attenuated Vaccine Product
 Table 104. Serum Institute Recent Developments/Updates
 Table 105. Key Raw Materials Lists
 Table 106. Raw Materials Key Suppliers Lists
 Table 107. Nasal Spray Live Attenuated Vaccine Distributors List
 Table 108. Nasal Spray Live Attenuated Vaccine Customers List
 Table 109. Nasal Spray Live Attenuated Vaccine Market Trends
 Table 110. Nasal Spray Live Attenuated Vaccine Market Drivers
 Table 111. Nasal Spray Live Attenuated Vaccine Market Challenges
 Table 112. Nasal Spray Live Attenuated Vaccine Market Restraints
 Table 113. Research Programs/Design for This Report
 Table 114. Key Data Information from Secondary Sources
 Table 115. Key Data Information from Primary Sources
 Table 116. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Nasal Spray Live Attenuated Vaccine
 Figure 2. Global Nasal Spray Live Attenuated Vaccine Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Nasal Spray Live Attenuated Vaccine Market Share by Type: 2025 & 2032
 Figure 4. Trivalent Nasal Spray Live Attenuated Vaccine Product Picture
 Figure 5. Quadrivalent Nasal Spray Live Attenuated Vaccine Product Picture
 Figure 6. Global Nasal Spray Live Attenuated Vaccine Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global Nasal Spray Live Attenuated Vaccine Market Share by Application: 2025 & 2032
 Figure 8. Hospitals & Clinics
 Figure 9. Public Health Organizations
 Figure 10. Research Organizations
 Figure 11. Others
 Figure 12. Global Nasal Spray Live Attenuated Vaccine Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 13. Global Nasal Spray Live Attenuated Vaccine Market Size (US$ Million), 2021–2032
 Figure 14. Global Nasal Spray Live Attenuated Vaccine Sales (K Dose), 2021–2032
 Figure 15. Global Nasal Spray Live Attenuated Vaccine Average Price (US$/Dose), 2021–2032
 Figure 16. Nasal Spray Live Attenuated Vaccine Report Years Considered
 Figure 17. Nasal Spray Live Attenuated Vaccine Sales Share by Manufacturers in 2025
 Figure 18. Global Nasal Spray Live Attenuated Vaccine Revenue Share by Manufacturers in 2025
 Figure 19. Top 5 and Top 10 Global Nasal Spray Live Attenuated Vaccine Players: Market Share by Revenue in Nasal Spray Live Attenuated Vaccine in 2025
 Figure 20. Nasal Spray Live Attenuated Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 21. Global Nasal Spray Live Attenuated Vaccine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 22. North America Nasal Spray Live Attenuated Vaccine Sales Market Share by Country (2021–2032)
 Figure 23. North America Nasal Spray Live Attenuated Vaccine Revenue Market Share by Country (2021–2032)
 Figure 24. United States Nasal Spray Live Attenuated Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Canada Nasal Spray Live Attenuated Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 26. Europe Nasal Spray Live Attenuated Vaccine Sales Market Share by Country (2021–2032)
 Figure 27. Europe Nasal Spray Live Attenuated Vaccine Revenue Market Share by Country (2021–2032)
 Figure 28. Germany Nasal Spray Live Attenuated Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. France Nasal Spray Live Attenuated Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. U.K. Nasal Spray Live Attenuated Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Italy Nasal Spray Live Attenuated Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Russia Nasal Spray Live Attenuated Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Asia Pacific Nasal Spray Live Attenuated Vaccine Sales Market Share by Region (2021–2032)
 Figure 34. Asia Pacific Nasal Spray Live Attenuated Vaccine Revenue Market Share by Region (2021–2032)
 Figure 35. China Nasal Spray Live Attenuated Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. Japan Nasal Spray Live Attenuated Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. South Korea Nasal Spray Live Attenuated Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. India Nasal Spray Live Attenuated Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Australia Nasal Spray Live Attenuated Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. China Taiwan Nasal Spray Live Attenuated Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Southeast Asia Nasal Spray Live Attenuated Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Latin America Nasal Spray Live Attenuated Vaccine Sales Market Share by Country (2021–2032)
 Figure 43. Latin America Nasal Spray Live Attenuated Vaccine Revenue Market Share by Country (2021–2032)
 Figure 44. Mexico Nasal Spray Live Attenuated Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Brazil Nasal Spray Live Attenuated Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Argentina Nasal Spray Live Attenuated Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Colombia Nasal Spray Live Attenuated Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Middle East and Africa Nasal Spray Live Attenuated Vaccine Sales Market Share by Country (2021–2032)
 Figure 49. Middle East and Africa Nasal Spray Live Attenuated Vaccine Revenue Market Share by Country (2021–2032)
 Figure 50. Turkey Nasal Spray Live Attenuated Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Saudi Arabia Nasal Spray Live Attenuated Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. UAE Nasal Spray Live Attenuated Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. Global Sales Market Share of Nasal Spray Live Attenuated Vaccine by Type (2021–2032)
 Figure 54. Global Revenue Market Share of Nasal Spray Live Attenuated Vaccine by Type (2021–2032)
 Figure 55. Global Nasal Spray Live Attenuated Vaccine Price (US$/Dose) by Type (2021–2032)
 Figure 56. Global Sales Market Share of Nasal Spray Live Attenuated Vaccine by Application (2021–2032)
 Figure 57. Global Revenue Market Share of Nasal Spray Live Attenuated Vaccine by Application (2021–2032)
 Figure 58. Global Nasal Spray Live Attenuated Vaccine Price (US$/Dose) by Application (2021–2032)
 Figure 59. Nasal Spray Live Attenuated Vaccine Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String